Persistently elevated levels of IL-1β, IL-6 and TNF-α create a microenvironment that favors sustained immune activation, resulting in continuous autoantibody production, lymphocyte activation and tissue damage at the NMJ, which explains the chronic progressive nature of MG. Here, IL1B is linked to myasthenia gravis.